RWA
AZN icon

Redhawk Wealth Advisors’s AstraZeneca AZN Stock Holding History

Redhawk Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-158
Closed -$13K – 156
2019
Q2 		$13K Buy
+158
New +$12.4K 0.01% 342

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Redhawk Wealth Advisors's AZN Position: Q3 2019 in Review

Redhawk Wealth Advisors sold out of AstraZeneca (AZN) in Q3 2019, closing a stake of 158 shares — an estimated $13K sold.

Redhawk Wealth Advisors first reported a position in AZN in Q2 2019 and held it in 1 quarter. The position peaked at $13K in Q2 2019. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

  • Redhawk Wealth Advisors reported no remaining AstraZeneca position as of Q3 2019 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 158 AstraZeneca shares in Q3 2019, an estimated $13K.
  • Redhawk Wealth Advisors first reported a position in AstraZeneca in Q2 2019 and held it in 1 quarter.
  • Redhawk Wealth Advisors's AstraZeneca position peaked at $13K in Q2 2019.
  • 555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2019, filed 4 Oct 2019.